Quantcast

Latest Phosphate binders Stories

2014-07-10 12:28:45

Interest in GCS-100, Velcalcetide, ST-10, GSK-1278863A and Rayaldee Ranges from Moderate to High, According to Findings from Decision Resources Group BURLINGTON, Mass., July 10, 2014 /PRNewswire/ -- Decision Resources Group finds that over half of surveyed nephrologists report awareness of the U.S. Food and Drug Administration's (FDA) approval of Vifor Fresenius Medical Care Renal Pharma's new phosphate binder Velphoro, which was approved by the FDA in November 2013 for the treatment of...

2014-05-15 08:32:20

Study will evaluate tenapanor for the treatment of hyperphosphatemia in ESRD patients on hemodialysis FREMONT, Calif., May 15, 2014 /PRNewswire/ -- Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, GI and metabolic diseases, today announced that it has received a $25 million milestone payment from AstraZeneca (NYSE:AZN, LON:AZN) for the initiation of a Phase 2b clinical trial evaluating tenapanor for the treatment of hyperphosphatemia, or elevated...

2014-04-22 12:30:10

Improved Pill Burden Scored Highest in Terms of Delivery Attributes, According to Findings from Decision Resources Group BURLINGTON, Mass., April 22, 2014 /PRNewswire/ -- Decision Resources Group finds that reduction in mortality, reduction in serum phosphorus levels, followed by improvement in renal anemia parameters were selected by surveyed nephrologists as the top three most persuasive efficacy clinical trial end points when prescribing a new drug for the treatment of hyperphosphatemia....

2014-03-18 20:20:37

DUBLIN, March 18, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/plhkq8/calcium) has announced the addition of the "Calcium Carbonate-Precipitated (CAS 471-34-1) Market Research Report" [http://www.researchandmarkets.com/research/plhkq8/calcium ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Calcium Carbonate-Precipitated (CAS 471-34-1) Market Research Report presents comprehensive...

2013-09-10 23:27:21

Approval of This Novel Phosphate Binder Will Be a Major Milestone for the Company Cary, NC (PRWEB) September 10, 2013 BioLink Life Sciences, Inc., a biopharmaceutical innovator, announced today that the U.S. Food & Drug Administration (FDA) has accepted its New Drug Application for PiLo™ (calcium succinate capsules) for review. PiLo™ is the Company's patented phosphate binder for the treatment of elevated blood phosphate in patients with end stage renal disease (ESRD). Upon...

2013-08-08 23:03:37

RenaGum™ is a new approach to helping people with chronic kidney disease (CKD) maintain normal phosphate levels. It is the first medical food that is not another pill or tablet you need to swallow, but a pleasant tasting sugar-free chewing gum made with natural ingredients. Hunt Valley, MD (PRWEB) August 08, 2013 Mastix Medica, an innovative specialty manufacturer of dietary supplements and functional foods, has introduced RenaGum™, a novel medical food that helps patients with...

2013-04-19 14:26:14

Dietary restriction may be the best way to reduce phosphate's negative effects on the heart Highlights: -The phosphate binder sevelamer carbonate did not improve cardiovascular measures in patients with early chronic kidney disease. -For now, reducing dietary intake of phosphate may be the best way for these patients to reduce the mineral's negative effects on the heart. -High phosphate levels–in kidney disease patients and in the general population–increase the risk of...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related